select trial semaglutide cardiovascular outcomes non-diabetic 2023 A emulation in Nature Medicine shows that treatment with and tirzepatide showed similar levels of benefit on in people at elevated cardiovascular risk with obesity and diabetes. Link A Skeptical Take of Semaglutide

Comfort, Technique, and Debunking Myths Theres plenty of misinformation floating around about administering semaglutide

for example, a phase 2 randomized trial demonstrated that once-weekly administration of semaglutide reduced alcohol craving and consumption in adults with alcohol use disorder [92], and meta-analytic data suggest improvements in emotional well-being and quality of life among individuals receiving GLP-1-based therapy [93]

Potential Mechanisms: How Semaglutide May Influence Menstrual Pain Semaglutide, a GLP-1 receptor agonist, works by regulating blood sugar, reducing appetite, and promoting weight loss

The patient has established cardiovascular disease (semaglutide has the SELECT trial showing a 20% reduction in major cardiac events[12]